Cargando…

Enteric Microbiome Metabolites Correlate with Response to Simvastatin Treatment

Although statins are widely prescribed medications, there remains considerable variability in therapeutic response. Genetics can explain only part of this variability. Metabolomics is a global biochemical approach that provides powerful tools for mapping pathways implicated in disease and in respons...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaddurah-Daouk, Rima, Baillie, Rebecca A., Zhu, Hongjie, Zeng, Zhao-Bang, Wiest, Michelle M., Nguyen, Uyen Thao, Wojnoonski, Katie, Watkins, Steven M., Trupp, Miles, Krauss, Ronald M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3192752/ https://www.ncbi.nlm.nih.gov/pubmed/22022402 http://dx.doi.org/10.1371/journal.pone.0025482

Ejemplares similares

Correction: Enteric Microbiome Metabolites Correlate with Response to Simvastatin Treatment
por: Kaddurah-Daouk, Rima, et al.
Publicado: (2013)

Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study
por: Kaddurah-Daouk, Rima, et al.
Publicado: (2010)

Metabolomics Reveals Amino Acids Contribute to Variation in Response to Simvastatin Treatment
por: Trupp, Miles, et al.
Publicado: (2012)

Metabolic Profiling of Patients with Schizophrenia
por: Kaddurah-Daouk, Rima
Publicado: (2006)

Gut Microbiome-Linked Metabolites in the Pathobiology of Major Depression With or Without Anxiety—A Role for Bile Acids
por: MahmoudianDehkordi, Siamak, et al.
Publicado: (2022)

Associations between purine metabolites and monoamine neurotransmitters in first-episode psychosis
por: Yao, Jeffrey K., et al.
Publicado: (2013)

Associations between Purine Metabolites and Clinical Symptoms in Schizophrenia
por: Yao, Jeffrey K., et al.
Publicado: (2012)

Lipidomics Reveals Early Metabolic Changes in Subjects with Schizophrenia: Effects of Atypical Antipsychotics
por: McEvoy, Joseph, et al.
Publicado: (2013)

Current Concepts in Pharmacometabolomics, Biomarker Discovery, and Precision Medicine
por: Beger, Richard D., et al.
Publicado: (2020)

Serum metabolites associated with brain amyloid beta deposition, cognition and dementia progression
por: Nho, Kwangsik, et al.
Publicado: (2021)

Synthesis, Characterization and Quantification of Simvastatin Metabolites and Impurities
por: Bhatia, Manish S., et al.
Publicado: (2011)

Polyunsaturated Fatty Acids and Their Metabolites in Hyperemesis Gravidarum
por: Lindberg, Richard, et al.
Publicado: (2020)

Sets of coregulated serum lipids are associated with Alzheimer's disease pathophysiology
por: Barupal, Dinesh Kumar, et al.
Publicado: (2019)

Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study
por: Varma, Vijay R., et al.
Publicado: (2018)

Effects of sample handling and storage on quantitative lipid analysis in human serum
por: Zivkovic, Angela M., et al.
Publicado: (2009)

Module-Based Association Analysis for Omics Data with Network Structure
por: Wang, Zhi, et al.
Publicado: (2015)

Metabolite Signature of Simvastatin Treatment Involves Multiple Metabolic Pathways
por: Fernandes Silva, Lilian, et al.
Publicado: (2022)

Generation and quality control of lipidomics data for the alzheimer’s disease neuroimaging initiative cohort
por: Barupal, Dinesh Kumar, et al.
Publicado: (2018)

Colon cancer chemopreventive effects of baicalein, an active enteric microbiome metabolite from baicalin
por: WANG, CHONG-ZHI, et al.
Publicado: (2015)

Microbiome for Mars: surveying microbiome connections to healthcare with implications for long-duration human spaceflight, virtual workshop, July 13, 2020
por: LaPelusa, Michael, et al.
Publicado: (2021)

A population pharmacokinetic model for simvastatin and its metabolites in children and adolescents
por: Ogungbenro, Kayode, et al.
Publicado: (2019)

Effects of Silymarin on the In Vivo Pharmacokinetics of Simvastatin and Its Active Metabolite in Rats
por: Li, Ying, et al.
Publicado: (2019)

Effects of compound K, an enteric microbiome metabolite of ginseng, in the treatment of inflammation associated colon cancer
por: Yao, Haiqiang, et al.
Publicado: (2018)

ZNF542P is a pseudogene associated with LDL response to simvastatin treatment
por: Kim, Kyungpil, et al.
Publicado: (2018)

Indoxyl sulfate, a gut microbiome-derived uremic toxin, is associated with psychic anxiety and its functional magnetic resonance imaging-based neurologic signature
por: Brydges, Christopher R., et al.
Publicado: (2021)

Pharmacometabolomics Reveals Racial Differences in Response to Atenolol Treatment
por: Wikoff, William R., et al.
Publicado: (2013)

Modulation of Immunological Pathways in Autistic and Neurotypical Lymphoblastoid Cell Lines by the Enteric Microbiome Metabolite Propionic Acid
por: Frye, Richard E., et al.
Publicado: (2017)

Homeostatic Imbalance of Purine Catabolism in First-Episode Neuroleptic-Naïve Patients with Schizophrenia
por: Yao, Jeffrey K., et al.
Publicado: (2010)

Comparing metabolomic and pathologic biomarkers alone and in combination for discriminating Alzheimer’s disease from normal cognitive aging
por: Motsinger-Reif, Alison A, et al.
Publicado: (2013)

Purine Pathway Implicated in Mechanism of Resistance to Aspirin Therapy: Pharmacometabolomics-Informed-Pharmacogenomics
por: Yerges-Armstrong, Laura M., et al.
Publicado: (2013)

Comparative brain metabolomics reveals shared and distinct metabolic alterations in Alzheimer’s disease and progressive supranuclear palsy
por: Batra, Richa, et al.
Publicado: (2023)

Ezetimibe/simvastatin vs simvastatin in coronary heart disease patients with or without diabetes
por: Rotella, Carlo M, et al.
Publicado: (2010)

Microbiome Associations of Therapeutic Enteral Nutrition
por: Shah, Rajesh, et al.
Publicado: (2014)

Autoimmune liver disease and the enteric microbiome
por: Glassner, Kerri, et al.
Publicado: (2018)

Alterations in Self-Aggregating Neuropeptides in Cerebrospinal Fluid of Patients with Parkinsonian Disorders
por: Zhu, Shaochun, et al.
Publicado: (2022)

Pharmacometabolomics Informs About Pharmacokinetic Profile of Methylphenidate
por: Kaddurah‐Daouk, Rima, et al.
Publicado: (2018)

Peripheral serum metabolomic profiles inform central cognitive impairment
por: Wang, Jingye, et al.
Publicado: (2020)

Serum metabolomic biomarkers of perceptual speed in cognitively normal and mildly impaired subjects with fasting state stratification
por: Borkowski, Kamil, et al.
Publicado: (2021)

Effects of SLCO1B1 Genetic Variant on Metabolite Profile in Participants on Simvastatin Treatment
por: Fernandes Silva, Lilian, et al.
Publicado: (2022)

CYP3A4*22 and CYP3A5*3 are associated with increased levels of plasma simvastatin concentrations in the cholesterol and pharmacogenetics study cohort
por: Kitzmiller, Joseph P., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tln0lb7pa401nptg5bl44a25hk